Dutton Associates Announces Investment Opinion: Interleukin Genetics Rating At Strong Speculative Buy In Update Coverage By Dutton Associates Chiropractic Economics April 29, 2008 Dutton Associates updates its coverage of Interleukin Genetics (AMEX:ILI) maintaining a Strong Speculative Buy Related Posts Email list building tools for chiropractors, health care professionals NFL QB Patrick Mahomes’ injury puts focus on patella dislocation Veterans receive a complimentary visit November 12-14 at Sherman’s Chiropractic Health Center Build strong immunity in patients of any age – Part 2 Considerations for working with aging patients